Cargando…
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis
Findings from previous studies reporting the levels of serum brain-derived neurotrophic factor (BDNF) in patients with Alzheimer’s disease (AD) and individuals with mild cognitive impairment (MCI) have been conflicting. Hence, we performed a meta-analysis to examine the aggregate levels of serum BDN...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358753/ https://www.ncbi.nlm.nih.gov/pubmed/30634650 http://dx.doi.org/10.3390/ijms20020257 |
_version_ | 1783392056535678976 |
---|---|
author | Ng, Ted Kheng Siang Ho, Cyrus Su Hui Tam, Wilson Wai San Kua, Ee Heok Ho, Roger Chun-Man |
author_facet | Ng, Ted Kheng Siang Ho, Cyrus Su Hui Tam, Wilson Wai San Kua, Ee Heok Ho, Roger Chun-Man |
author_sort | Ng, Ted Kheng Siang |
collection | PubMed |
description | Findings from previous studies reporting the levels of serum brain-derived neurotrophic factor (BDNF) in patients with Alzheimer’s disease (AD) and individuals with mild cognitive impairment (MCI) have been conflicting. Hence, we performed a meta-analysis to examine the aggregate levels of serum BDNF in patients with AD and individuals with MCI, in comparison with healthy controls. Fifteen studies were included for the comparison between AD and healthy control (HC) (n = 2067). Serum BDNF levels were significantly lower in patients with AD (SMD: −0.282; 95% confidence interval [CI]: −0.535 to −0.028; significant heterogeneity: I(2) = 83.962). Meta-regression identified age (p < 0.001) and MMSE scores (p < 0.001) to be the significant moderators that could explain the heterogeneity in findings in these studies. Additionally, there were no significant differences in serum BDNF levels between patients with AD and MCI (eight studies, n = 906) and between MCI and HC (nine studies, n = 5090). In all, patients with AD, but not MCI, have significantly lower serum BDNF levels compared to healthy controls. This meta-analysis confirmed the direction of change in serum BDNF levels in dementia. This finding suggests that a significant change in peripheral BDNF levels can only be detected at the late stage of the dementia spectrum. Molecular mechanisms, implications on interventional trials, and future directions for studies examining BDNF in dementia were discussed. |
format | Online Article Text |
id | pubmed-6358753 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-63587532019-02-06 Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis Ng, Ted Kheng Siang Ho, Cyrus Su Hui Tam, Wilson Wai San Kua, Ee Heok Ho, Roger Chun-Man Int J Mol Sci Review Findings from previous studies reporting the levels of serum brain-derived neurotrophic factor (BDNF) in patients with Alzheimer’s disease (AD) and individuals with mild cognitive impairment (MCI) have been conflicting. Hence, we performed a meta-analysis to examine the aggregate levels of serum BDNF in patients with AD and individuals with MCI, in comparison with healthy controls. Fifteen studies were included for the comparison between AD and healthy control (HC) (n = 2067). Serum BDNF levels were significantly lower in patients with AD (SMD: −0.282; 95% confidence interval [CI]: −0.535 to −0.028; significant heterogeneity: I(2) = 83.962). Meta-regression identified age (p < 0.001) and MMSE scores (p < 0.001) to be the significant moderators that could explain the heterogeneity in findings in these studies. Additionally, there were no significant differences in serum BDNF levels between patients with AD and MCI (eight studies, n = 906) and between MCI and HC (nine studies, n = 5090). In all, patients with AD, but not MCI, have significantly lower serum BDNF levels compared to healthy controls. This meta-analysis confirmed the direction of change in serum BDNF levels in dementia. This finding suggests that a significant change in peripheral BDNF levels can only be detected at the late stage of the dementia spectrum. Molecular mechanisms, implications on interventional trials, and future directions for studies examining BDNF in dementia were discussed. MDPI 2019-01-10 /pmc/articles/PMC6358753/ /pubmed/30634650 http://dx.doi.org/10.3390/ijms20020257 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ng, Ted Kheng Siang Ho, Cyrus Su Hui Tam, Wilson Wai San Kua, Ee Heok Ho, Roger Chun-Man Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis |
title | Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis |
title_full | Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis |
title_fullStr | Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis |
title_full_unstemmed | Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis |
title_short | Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis |
title_sort | decreased serum brain-derived neurotrophic factor (bdnf) levels in patients with alzheimer’s disease (ad): a systematic review and meta-analysis |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6358753/ https://www.ncbi.nlm.nih.gov/pubmed/30634650 http://dx.doi.org/10.3390/ijms20020257 |
work_keys_str_mv | AT ngtedkhengsiang decreasedserumbrainderivedneurotrophicfactorbdnflevelsinpatientswithalzheimersdiseaseadasystematicreviewandmetaanalysis AT hocyrussuhui decreasedserumbrainderivedneurotrophicfactorbdnflevelsinpatientswithalzheimersdiseaseadasystematicreviewandmetaanalysis AT tamwilsonwaisan decreasedserumbrainderivedneurotrophicfactorbdnflevelsinpatientswithalzheimersdiseaseadasystematicreviewandmetaanalysis AT kuaeeheok decreasedserumbrainderivedneurotrophicfactorbdnflevelsinpatientswithalzheimersdiseaseadasystematicreviewandmetaanalysis AT horogerchunman decreasedserumbrainderivedneurotrophicfactorbdnflevelsinpatientswithalzheimersdiseaseadasystematicreviewandmetaanalysis |